Close | |
![]() |
|
Figure 2: (a) Neoplastic cells showing strong positivity for cytokeratin (IHC × 200), (b) Loss of INI1(SMARCB1) expression by tumor cells with retained expression by lymphocytes (IHC × 200) (c) negative staining for p63(IHC × 200), (d) negative staining for EBER (IHC × 200) |
|